Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.

Aldoss I, Pham A, Li SM, Gendzekhadze K, Afkhami M, Telatar M, Hong H, Padeganeh A, Bedell V, Cao T, Khaled SK, Malki MMA, Salhotra A, Ali H, Aribi A, Palmer J, Aoun P, Spielberger R, Stein AS, Snyder D, O'Donnell MR, Murata-Collins J, Senitzer D, Weisenburger D, Forman SJ, Pullarkat V, Marcucci G, Pillai R, Nakamura R.

Haematologica. 2017 Dec;102(12):2030-2038. doi: 10.3324/haematol.2017.172544. Epub 2017 Sep 29.

2.

Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases.

Cho M, Akiba C, Lau C, Smith D, Telatar M, Afkhami M, Sentovich S, Melstrom K, Fakih M.

World J Gastrointest Oncol. 2016 Jan 15;8(1):128-35. doi: 10.4251/wjgo.v8.i1.128.

3.

Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.

Pratt VM, Zehnbauer B, Wilson JA, Baak R, Babic N, Bettinotti M, Buller A, Butz K, Campbell M, Civalier C, El-Badry A, Farkas DH, Lyon E, Mandal S, McKinney J, Muralidharan K, Noll L, Sander T, Shabbeer J, Smith C, Telatar M, Toji L, Vairavan A, Vance C, Weck KE, Wu AH, Yeo KT, Zeller M, Kalman L.

J Mol Diagn. 2010 Nov;12(6):835-46. doi: 10.2353/jmoldx.2010.100090. Epub 2010 Oct 1.

4.

Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, Schrijver I, Shrimpton AE, Spector E, Telatar M, Toji L, Weck K, Zehnbauer B, Kalman LV.

J Mol Diagn. 2009 Nov;11(6):553-61. doi: 10.2353/jmoldx.2009.090078. Epub 2009 Sep 18.

5.

Infant hearing loss and connexin testing in a diverse population.

Schimmenti LA, Martinez A, Telatar M, Lai CH, Shapiro N, Fox M, Warman B, McCarra M, Crandall B, Sininger Y, Grody WW, Palmer CG.

Genet Med. 2008 Jul;10(7):517-24. doi: 10.1097GIM.0b013e31817708fa.

PMID:
18580690
6.

A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics.

Jarvis M, Iyer RK, Williams LO, Noll WW, Thomas K, Telatar M, Grody WW.

J Mol Diagn. 2005 May;7(2):247-51.

7.

Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.

Erem C, Hacihasanoğlu A, Celik S, Ovali E, Ersöz HO, Ukinç K, Deger O, Telatar M.

Med Princ Pract. 2005 Jan-Feb;14(1):22-30.

8.

Genetic testing as part of the early hearing detection and intervention (EHDI) process.

Schimmenti LA, Martinez A, Fox M, Crandall B, Shapiro N, Telatar M, Sininger Y, Grody WW, Palmer CG.

Genet Med. 2004 Nov-Dec;6(6):521-5. No abstract available.

PMID:
15545749
9.

Prevalence of obesity and associated risk factors in a Turkish population (trabzon city, Turkey).

Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, Ersöz HO, Telatar M.

Obes Res. 2004 Jul;12(7):1117-27.

10.

Sphenoid sinus brown tumor, a mass lesion of occipital bone and hypercalcemia: an unusual presentation of primary hyperparathyroidism.

Erem C, Hacihasanoglu A, Cinel A, Ersöz HO, Reis A, Sari A, Köse M, Ukinç K, Telatar M.

J Endocrinol Invest. 2004 Apr;27(4):366-9.

PMID:
15233558
11.

Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study.

Ersoz HO, Ukinc K, Baykan M, Erem C, Durmus I, Hacihasanoglu A, Telatar M.

Int J Obes Relat Metab Disord. 2004 Mar;28(3):378-83.

PMID:
14724665
12.

Screening for gestational diabetes mellitus in northeastern Turkey (Trabzon City).

Erem C, Cihanyurdu N, Deger O, Karahan C, Can G, Telatar M.

Eur J Epidemiol. 2003;18(1):39-43.

PMID:
12705622
13.

Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma.

Emmanouilides C, Lill M, Telatar M, Rosenfelt F, Grody W, Territo M, Rosen P.

Clin Lymphoma. 2002 Sep;3(2):111-6.

PMID:
12435284
14.

Blood coagulation and fibrinolysis in patients with hyperthyroidism.

Erem C, Ersoz HO, Karti SS, Ukinç K, Hacihasanoglu A, Değer O, Telatar M.

J Endocrinol Invest. 2002 Apr;25(4):345-50.

PMID:
12030606
15.

Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.

Emmanouilides C, Rosen P, Telatar M, Malone R, Bosserman L, Menco H, Patel R, Barstis J, Grody WW.

Clin Lymphoma. 2000 Sep;1(2):146-51; discussion 152-3.

PMID:
11707827
16.

Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city).

Erem C, Yildiz R, Kavgaci H, Karahan C, Deger O, Can G, Telatar M.

Diabetes Res Clin Pract. 2001 Dec;54(3):203-8.

PMID:
11689275
17.

Detection of bcl-2/IgH rearrangements by quantitative-competitive PCR and capillary electrophoresis.

Telatar M, Grody WW, Emmanouilides C.

Mol Diagn. 2001 Sep;6(3):161-8.

PMID:
11571709
18.

Thyroid function tests in pregnant women with and without goiter in the eastern Black Sea region.

Erem C, Kavgaci H, Karahan C, Mocan MZ, Telatar M.

Gynecol Endocrinol. 2001 Aug;15(4):293-7.

PMID:
11560103
19.

Molecular genetic testing for familial Mediterranean fever.

Telatar M, Grody WW.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):256-60. Review. No abstract available.

PMID:
11001819
20.

Value of resistive index in patients with clinical diabetic nephropathy.

Sari A, Dinc H, Zibandeh A, Telatar M, Gümele HR.

Invest Radiol. 1999 Nov;34(11):718-21.

PMID:
10548384
21.

Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.

Erem C, Değer O, Bostan M, Orem A, Sönmez M, Ulusoy S, Telatar M.

Acta Cardiol. 1999 Aug;54(4):203-7.

PMID:
10511896
22.

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer.

Bebb DG, Yu Z, Chen J, Telatar M, Gelmon K, Phillips N, Gatti RA, Glickman BW.

Br J Cancer. 1999 Aug;80(12):1979-81.

23.

New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy.

Castellví-Bel S, Sheikhavandi S, Telatar M, Tai LQ, Hwang M, Wang Z, Yang Z, Cheng R, Gatti RA.

Hum Mutat. 1999;14(2):156-62.

PMID:
10425038
24.

Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.

Erem C, Değer O, Bostan M, Orem A, Sönmez M, Ulusoy S, Telatar M.

Acta Cardiol. 1999 Apr;54(2):77-81.

PMID:
10378018
25.

Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengüt S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P.

Am J Hum Genet. 1999 Jun;64(6):1617-31.

26.

Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect.

Laake K, Telatar M, Geitvik GA, Hansen RO, Heiberg A, Andresen AM, Gatti R, Børresen-Dale AL.

Eur J Hum Genet. 1998 May-Jun;6(3):235-44.

27.

A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia.

Telatar M, Wang S, Castellvi-Bel S, Tai LQ, Sheikhavandi S, Regueiro JR, Porras O, Gatti RA.

Mol Genet Metab. 1998 May;64(1):36-43.

PMID:
9682216
28.

Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations.

Telatar M, Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bel S, Udar N, Borresen-Dale AL, Chessa L, Bernatowska-Matuszkiewicz E, Porras O, Watanabe M, Junker A, Concannon P, Gatti RA.

Am J Hum Genet. 1998 Jan;62(1):86-97.

29.

Friedreich's ataxia GAA repeat expansion in patients with recessive or sporadic ataxia.

Geschwind DH, Perlman S, Grody WW, Telatar M, Montermini L, Pandolfo M, Gatti RA.

Neurology. 1997 Oct;49(4):1004-9.

PMID:
9339680
30.

CAND3: A ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 1lq23.1.

Chen X, Yang L, Udar N, Liang T, Uhrhammer N, Xu S, Bay JO, Wang Z, Dandakar S, Chiplunkar S, Klisak I, Telatar M, Yang H, Concannon P, Gatti RA.

Mamm Genome. 1997 Feb;8(2):129-33. doi: 10.1007/s003359900371.

PMID:
27518307
31.

CAND3: a ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 11q23.1.

Chen X, Yang L, Udar N, Liang T, Uhrhammer N, Xu S, Bay JO, Wang Z, Dandakar S, Chiplunkar S, Klisak I, Telatar M, Yang H, Concannon P, Gatti RA.

Mamm Genome. 1997 Feb;8(2):129-33.

PMID:
9060412
32.

Myocardial perfusion scintigraphy in a myocardial bridging of coronary artery.

Kulan K, Kulan C, Tuncer C, Komsuoğlu B, Telatar M.

Clin Nucl Med. 1996 Nov;21(11):888-9. No abstract available.

PMID:
8922859
33.

Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening.

Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, Concannon P, Good RA, Gatti RA.

Am J Hum Genet. 1996 Jul;59(1):40-4.

34.

New localization of NCAM, proximal to DRD2 at chromosome 11q23.

Telatar M, Lange E, Uhrhammer N, Gatti RA.

Mamm Genome. 1995 Jan;6(1):59-60. No abstract available.

PMID:
7719033
35.

Identification of a one-basepair deletion in exon 6 of the dystrophin gene.

Kavaslar GN, Telatar M, Serdaroglu P, Deymeer F, Ozdemir C, Tolun A.

Hum Mutat. 1995;6(1):85-6. No abstract available.

PMID:
7550238
36.

Dinucleotide repeat polymorphism at 11q23.

Telatar M, Concannon P, Tolun A.

Hum Genet. 1994 Jul;94(1):109.

PMID:
8034289
37.

Dinucleotide repeat polymorphism at the NCAM locus.

Telatar M, Concannon P, Tolun A.

Hum Mol Genet. 1994 May;3(5):842. No abstract available.

PMID:
8081382
38.

Cystic fibrosis patients from the Black Sea region: the 1677delTA mutation.

Angelicheva D, Boteva K, Jordanova A, Savov A, Kufardjieva A, Tolun A, Telatar M, Akarsubaşi A, Köprübaşi F, Aydoğdu S, et al.

Hum Mutat. 1994;3(4):353-7.

PMID:
8081388
40.

Papillary carcinoma in a thyroglossal duct remnant with normal thyroid gland.

Yildiz K, Köksal H, Ozoran Y, Muhtar H, Telatar M.

J Laryngol Otol. 1993 Dec;107(12):1174-6.

PMID:
8289014
41.
43.

DNA analysis in Turkish Duchenne/Becker muscular dystrophy families.

Battaloğlu E, Telatar M, Deymeer F, Serdaroğlu P, Kuseyri F, Ozdemir C, Apak M, Tolun A.

Hum Genet. 1992 Aug;89(6):635-9.

PMID:
1355068
44.

Ataxia-telangiectasia: linkage analysis of chromosome 11q22-23 markers in Turkish families.

Sanal O, Lange E, Telatar M, Sobel E, Salazar-Novak J, Ersoy F, Morrison A, Concannon P, Tolun A, Gatti RA.

FASEB J. 1992 Jul;6(10):2848-52.

PMID:
1634048
45.

Carrier detection by DNA analysis in Duchenne muscular dystrophy families.

Battaloğlu E, Telatar M, Deymeer F, Serdaroğlu P, Ozdemir C, Kuseyri F, Apak MY, Tolun A.

Turk J Pediatr. 1992 Apr-Jun;34(2):79-92.

PMID:
1440954
46.

Preventive measures after the Turkish flood disaster.

Beşer E, Köksal I, Telatar M, Okten A, Beşer A.

World Health Forum. 1991;12(4):445-6. No abstract available.

PMID:
1821108

Supplemental Content

Loading ...
Support Center